Prof. Fabrice André is President of the European Society for Medical Oncology (ESMO) for the 2025–2026 term and Director of Research at Gustave Roussy, where he also serves as Professor in the Department of Medical Oncology. A specialist in breast cancer and precision oncology, he leads the Inserm U981 research unit on predictive biomarkers and personalised therapies. He is the author or co-author of more than 350 scientific publications and is listed among the Highly Cited Researchers (Web of Science). Ranked among the 25 most influential figures in precision medicine by BIS Research, he is a recipient of the ASCO Young Investigator and Career Development Awards and served as Editor-in-Chief of Annals of Oncology from 2017 to 2023.